Prostate Radiotherapy
Cross-source consensus on Prostate Radiotherapy from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Dosage & preparation
Preparation
Background
Highlighted claims
- DESTINATION 2 delivers all treatment with MRI-guided adaptive radiotherapy on an MR-linac. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- The uniform-dose arm delivers 27 Gy to the whole prostate or clinical target volume in two fractions. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- The de-escalated arm gives a lower whole-gland dose plus focal tumor boost. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- Radiotherapy for localized prostate cancer has shifted toward hypofractionated and ultra-hypofractionated SBRT schedules supported by level 1 evidence. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial
- Two-fraction schedules are supported by HDR brachytherapy data and the low alpha/beta ratio of prostate cancer. — Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial